Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cyclacel Pharmaceuti
(NQ:
CYCC
)
1.850
-0.110 (-5.61%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
37,911
Open
1.910
Bid (Size)
1.790 (1)
Ask (Size)
1.990 (4)
Prev. Close
1.960
Today's Range
1.810 - 1.960
52wk Range
0.2310 - 4.378
Shares Outstanding
1,318,257
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 11, 2024
Via
Benzinga
Performance
YTD
-30.19%
-30.19%
1 Month
-21.28%
-21.28%
3 Month
-10.63%
-10.63%
6 Month
+188.16%
+188.16%
1 Year
+172.06%
+172.06%
More News
Read More
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer
April 01, 2024
From
Cyclacel
Via
GlobeNewswire
CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023
March 19, 2024
Via
InvestorPlace
Earnings Outlook For Cyclacel Pharmaceuticals
March 18, 2024
Via
Benzinga
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 19, 2024
From
Cyclacel
Via
GlobeNewswire
Earnings Scheduled For March 19, 2024
March 19, 2024
Via
Benzinga
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
March 13, 2024
From
Cyclacel
Via
GlobeNewswire
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
March 07, 2024
From
Cyclacel
Via
GlobeNewswire
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
March 06, 2024
From
Cyclacel
Via
GlobeNewswire
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference
February 20, 2024
From
Cyclacel
Via
GlobeNewswire
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
January 30, 2024
From
Cyclacel
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
January 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 12, 2024
Via
Benzinga
RKLB Stock Alert: The $500 Million Reason Rocket Lab Is Moving Today
January 09, 2024
Via
InvestorPlace
Unity Layoffs 2024: What to Know About the Latest U Job Cuts
January 09, 2024
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today?
January 09, 2024
Via
InvestorPlace
Why Juniper Networks Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
January 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 09, 2024
Via
InvestorPlace
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
January 08, 2024
From
Cyclacel
Via
GlobeNewswire
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via
Benzinga
Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
January 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 08, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 08, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.